flâneur

U.S. sidelines methadone and buprenorphine despite opioid crisis - STAT

statnews.com · 4,478 words · saved by 1 readers

You're reading Part 1 of The War on Recovery, a yearlong investigation into how the U.S. denies lifesaving medications to people with opioid addiction. Part 2 coming March 12 T he opioid overdose epidemic has burned through the U.S. for nearly 30 years. Yet for all that time, the country has had tools that are highly effective at preventing overdose deaths: methadone and buprenorphine. These medicines are cheap and easy to distribute. People who take them use illicit drugs at far lower rates, and are at far lower risk of overdose or death. By beating back the cravings and agonizing withdrawal symptoms that result from trying to quit opioids “cold turkey,” methadone and buprenorphine can help people addicted to opioids escape an existence defined by drugs and achieve stable, healthy lives. advertisement But a yearlong investigation by STAT shows that virtually every sector of American society is obstructing the use of medications that could prevent tens of thousands of deaths each year.

You're reading Part 1 of The War on Recovery , a yearlong investigation into how the U.S. denies lifesaving medications to people with opioid addiction. T he opioid overdose epidemic has burned through the U.S. for nearly 30 years. Yet for all that time, the country has had tools that are highly effective at preventing overdose deaths: methadone and buprenorphine . These medicines are cheap and easy to distribute. People who take them use illicit drugs at far lower rates, and are at far lower risk of overdose or death. By beating back the cravings and agonizing withdrawal symptoms that result

related reading